A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
Clinical trial NCT06585241 · RECRUITING
Trial details
- NCT number
- NCT06585241
- Sponsor
- ModernaTX, Inc.
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-09
- Primary completion
- 2026-12-31
- Enrollment
- 1144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.